Patents by Inventor Kenneth W. Sell

Kenneth W. Sell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6491925
    Abstract: Disclosed are compositions and methods to generate a protective or therapeutic immune response to neoplastic cells (e.g., tumor cells) which, in nature, lack a CoCAM surface molecule essential for a cytotoxic immune response. GPI-anchored CoCAM molecules are incorporated (by GPI-protein transfer) into neoplastic cells, neoplastic cell membrane preparations or neoplastic membrane vesicle preparations and formulated in immunogenic compositions. A specifically exemplified GPI-CoCAM is a B7.1/CD16B fusion protein, having the GPI anchor domain from the CD16B molecule.
    Type: Grant
    Filed: August 15, 1997
    Date of Patent: December 10, 2002
    Assignee: Emory University
    Inventors: Periasmy Selvaraj, Kenneth W. Sell
  • Publication number: 20020009468
    Abstract: Disclosed are compositions and methods to generate a protective or therapeutic immune response to neoplastic cells (e.g., tumor cells) which, in nature, lack a CoCAM surface molecule essential for a cytotoxic immune response. GPI-anchored CoCAM molecules are incorporated (by GPI-protein transfer) into neoplastic cells, neoplastic cell membrane preparations or neoplastic membrane vesicle preparations and formulated in immunogenic compositions. A specifically exemplified GPI-CoCAM is a B7.1/CD16B fusion protein, having the GPI anchor domain from the CD16B molecule.
    Type: Application
    Filed: August 15, 1997
    Publication date: January 24, 2002
    Inventors: PERIASAMY SELVARAJ, KENNETH W. SELL
  • Patent number: 5635365
    Abstract: The present invention provides a noninvasive method for diagnosing and/or predicting a rejection episode in a transplant patient, for example, in a heart transplant patient, by determining a rise in the frequency of thioguanine-resistant mutant peripheral blood mononuclear cells. Those resistant mutant cells have a deficiency in the purine salvage enzyme hypoxanthine guanine phosphoribosyltransferase. The relative frequency of the mutant cells in the population from a sample can be determined by direct plating in the presence of a selection medium and by determining of the mutation by polymerase chain reaction technology.
    Type: Grant
    Filed: August 7, 1995
    Date of Patent: June 3, 1997
    Assignee: Emory University
    Inventors: Aftab A. Ansari, Francois Villinger, Kenneth W. Sell
  • Patent number: 3935308
    Abstract: A preparation and a method are described for emergency, interim treatment extensive burn injuries, e.g., flash burns, to external portions of a person. A solution of the polymer poly-.epsilon.-caprolactone is a volatile solvent, such as acetone or tetrahydrofuran, is applied to the burn area by spraying or swabbing, so that upon evaporation of the solvent a film of the polymer is left to serve as a barrier to insensible water loss.
    Type: Grant
    Filed: August 8, 1974
    Date of Patent: January 27, 1976
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Donald L. Wise, Arthur D. Schwope, Kenneth W. Sell